Novo Nordisk Inc and Novo Nordisk A/S v Viatris Inc and Mylan Pharmaceuticals, 1:23-cv-00101 and Novo Nordisk Inc and Novo Nordisk A/S v Sun Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries, Inc, 1:23-cv-01459 17 The drop in patent filings observed in 2023 may reflect several factors
Only some examples from the literature regarding this issue are mentioned below
Hashimotos affects far more than thyroid hormone levels
Many patients are surprised to learn they've gained muscle mass while the scale drops, because muscle is denser than fat and weighs more by volume
Individual results vary based upon age, medical disorders, adherence to lifestyle changes but many clients find that the dual mechanism of two medicines offer more robust appetite suppression and metabolic control, leading to more weight loss
Always monitor the medications appearance before each dose